128 related articles for article (PubMed ID: 17440066)
1. A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans.
Haiman CA; Setiawan VW; Xia LY; Le Marchand L; Ingles SA; Ursin G; Press MF; Bernstein L; John EM; Henderson BE
Cancer Res; 2007 Apr; 67(8):3565-8. PubMed ID: 17440066
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
3. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.
Kato I; Cichon M; Yee CL; Land S; Korczak JF
Cancer Epidemiol; 2009 Jul; 33(1):24-30. PubMed ID: 19679043
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO
PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315
[TBL] [Abstract][Full Text] [Related]
5. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF;
Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
Breast Cancer Res; 2004; 6(4):R460-73. PubMed ID: 15217514
[TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
[TBL] [Abstract][Full Text] [Related]
8. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
9. Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.
Huang N; Agrawal V; Giacomini KM; Miller WL
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1733-8. PubMed ID: 18230729
[TBL] [Abstract][Full Text] [Related]
10. Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women.
Ruiz-Narváez EA; Rosenberg L; Yao S; Rotimi CN; Cupples AL; Bandera EV; Ambrosone CB; Adams-Campbell LL; Palmer JR
Carcinogenesis; 2013 Feb; 34(2):287-91. PubMed ID: 23104177
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study.
Ruiz-Narvaez EA; Rosenberg L; Rotimi CN; Cupples LA; Boggs DA; Adeyemo A; Cozier YC; Adams-Campbell LL; Palmer JR
Breast Cancer Res Treat; 2010 Sep; 123(2):525-30. PubMed ID: 20140701
[TBL] [Abstract][Full Text] [Related]
12. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer.
Huo D; Feng Y; Haddad S; Zheng Y; Yao S; Han YJ; Ogundiran TO; Adebamowo C; Ojengbede O; Falusi AG; Zheng W; Blot W; Cai Q; Signorello L; John EM; Bernstein L; Hu JJ; Ziegler RG; Nyante S; Bandera EV; Ingles SA; Press MF; Deming SL; Rodriguez-Gil JL; Nathanson KL; Domchek SM; Rebbeck TR; Ruiz-Narváez EA; Sucheston-Campbell LE; Bensen JT; Simon MS; Hennis A; Nemesure B; Leske MC; Ambs S; Chen LS; Qian F; Gamazon ER; Lunetta KL; Cox NJ; Chanock SJ; Kolonel LN; Olshan AF; Ambrosone CB; Olopade OI; Palmer JR; Haiman CA
Hum Mol Genet; 2016 Nov; 25(21):4835-4846. PubMed ID: 28171663
[TBL] [Abstract][Full Text] [Related]
14. Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant.
Palmer ND; Hester JM; An SS; Adeyemo A; Rotimi C; Langefeld CD; Freedman BI; Ng MC; Bowden DW
Diabetes; 2011 Feb; 60(2):662-8. PubMed ID: 20980453
[TBL] [Abstract][Full Text] [Related]
15. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in the mTOR pathway and breast cancer risk in African American women.
Cheng TD; Ambrosone CB; Hong CC; Lunetta KL; Liu S; Hu Q; Yao S; Sucheston-Campbell L; Bandera EV; Ruiz-Narváez EA; Haddad S; Troester MA; Haiman CA; Bensen JT; Olshan AF; Palmer JR; Rosenberg L
Carcinogenesis; 2016 Jan; 37(1):49-55. PubMed ID: 26577839
[TBL] [Abstract][Full Text] [Related]
17. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
Haiman CA; Garcia RR; Hsu C; Xia L; Ha H; Sheng X; Le Marchand L; Kolonel LN; Henderson BE; Stallcup MR; Greene GL; Press MF
BMC Cancer; 2009 Jan; 9():43. PubMed ID: 19183483
[TBL] [Abstract][Full Text] [Related]
18. Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.
Ruiz-Narváez EA; Haddad SA; Lunetta KL; Yao S; Bensen JT; Sucheston-Campbell LE; Hong CC; Haiman CA; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2016 Jan; 155(2):355-63. PubMed ID: 26743380
[TBL] [Abstract][Full Text] [Related]
19. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
[TBL] [Abstract][Full Text] [Related]
20. Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population.
Li H; Li S; Wang Q; Jia C
Hum Genet; 2016 Dec; 135(12):1389-1397. PubMed ID: 27660057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
